title: Treatment of multiple myeloma in patients with Gaucher disease.
authors.forename: Maciej
authors.initials: M
authors.lastname: Machaczka
authors.forename: Richard
authors.initials: R
authors.lastname: Lerner
authors.forename: Monika
authors.initials: M
authors.lastname: Klimkowska
authors.forename: Hans
authors.initials: H
authors.lastname: Hägglund
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D017809:Fatal Outcome; D005776:Gaucher Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000150:complications / Q000188:drug therapy
chemical_list: D018906:Antineoplastic Agents, Alkylating; D007136:Immunoglobulins; C009823:M-proteins (Myeloma); D008558:Melphalan; D011241:Prednisone